The proposed mechanism of kefir-peptides-mediated modulation of the lipid metabolism in fructose-induced NAFLD mice through the JAK2 pathway is shown in Figure 4. Here, JAK2 is linked to metabolic dysfunction-associated steatotic liver disease.